Results 151 to 160 of about 5,881 (166)

Chemoproteomic Profiling of Covalent XPO1 Inhibitors to Assess Target Engagement and Selectivity

ChemBioChem, 2021
Kilian Huber, Jennifer A Ward, Jeffrey Martin   +2 more
exaly  

Interaction with XPO1 is essential for SETBP1 to induce myeloid transformation

Leukemia, 2019
Nhu, Nguyen, Kevin, Oakley, Yufen, Han, Mary, Kwok, Gary, Crouch, Yang, Du   +5 more
openaire   +2 more sources

Induction of p53‐mediated transcription and apoptosis by exportin‐1 (XPO1) inhibition in mantle cell lymphoma

Cancer Science, 2014
Michael Andreeff, Larry Kwak, Sattva Neelapu   +2 more
exaly  

Genome-wide studies in multiple myeloma identify XPO1/CRM1 as a critical target validated using the selective nuclear export inhibitor KPT-276

Leukemia, 2013
Rodger Tiedemann, M Kauffman, Bergsagel P L   +2 more
exaly  

XPO1 INHIBITORS FOR USE IN TREATING CANCER

2021
LANDESMAN YOSEF, WALKER CHRISTOPHER, CALIFANO ANDREA, ALVAREZ MARIANO, SHEN YAO   +4 more
openaire   +3 more sources

CRM1/XPO1 (exportin)

2008
openaire   +1 more source

Selinexor. Exportin-1 (XPO1) inhibitor, Oncolytic

Drugs of the Future, 2014
null Riaz, W., null Burke, N., null Mahipal, A.   +2 more
openaire   +1 more source

DNA-Methylation-Caused Downregulation of miR-30 Contributes to the High Expression of XPO1 and the Aggressive Growth of Tumors in Pancreatic Ductal Adenocarcinoma

Cancers, 2019
Ramzi Mohammad, Philip Philip, Asfar Azmi   +2 more
exaly  

NEDD4 protects vascular endothelial cells against Angiotensin II-induced cell death via enhancement of XPO1-mediated nuclear export

Experimental Cell Research, 2019
Meng Wang
exaly  

Clinical Implications of Targeting XPO1-mediated Nuclear Export in Multiple Myeloma

Clinical Lymphoma, Myeloma and Leukemia, 2018
Ajai Chari, Robert Cornell, Dan T Vogl
exaly